Fifth Third Bancorp Halozyme Therapeutics, Inc. Transaction History

Fifth Third Bancorp

  • $27.1 Billion
  • Q4 2024

A detailed history of Fifth Third Bancorp transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 7,741 shares of HALO stock, worth $504,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,741
Previous 7,799 0.74%
Holding current value
$504,403
Previous $446,000 17.04%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
SELL
$42.57 - $61.09 $2,469 - $3,543
-58 Reduced 0.74%
7,741 $370,000
Q3 2024

Oct 17, 2024
SELL
$51.3 - $64.42 $174,779 - $219,478
-3,407 Reduced 30.4%
7,799 $446,000
Q2 2024

Jul 22, 2024
BUY
$37.81 - $52.4 $9,868 - $13,676
261 Added 2.38%
11,206 $586,000
Q1 2024

Apr 23, 2024
SELL
$33.68 - $41.95 $842 - $1,048
-25 Reduced 0.23%
10,945 $445,000
Q4 2023

Jan 19, 2024
SELL
$33.32 - $42.1 $43,049 - $54,393
-1,292 Reduced 10.54%
10,970 $405,000
Q3 2023

Oct 31, 2023
BUY
$36.46 - $44.03 $11,229 - $13,561
308 Added 2.58%
12,262 $468,000
Q2 2023

Jul 25, 2023
BUY
$30.28 - $38.74 $54,352 - $69,538
1,795 Added 17.67%
11,954 $431,000
Q1 2023

Apr 24, 2023
SELL
$32.86 - $55.7 $89,576 - $151,838
-2,726 Reduced 21.16%
10,159 $387,000
Q4 2022

Jan 25, 2023
SELL
$40.06 - $59.44 $46,069 - $68,356
-1,150 Reduced 8.19%
12,885 $0
Q3 2022

Oct 25, 2022
SELL
$38.53 - $51.78 $346 - $466
-9 Reduced 0.06%
14,035 $555,000
Q2 2022

Aug 04, 2022
SELL
$37.35 - $48.3 $1,792 - $2,318
-48 Reduced 0.34%
14,044 $618,000
Q1 2022

Apr 19, 2022
BUY
$31.97 - $41.06 $73,499 - $94,396
2,299 Added 19.49%
14,092 $562,000
Q4 2021

Feb 01, 2022
BUY
$31.82 - $40.75 $16,991 - $21,760
534 Added 4.74%
11,793 $474,000
Q3 2021

Oct 15, 2021
BUY
$38.47 - $46.42 $16,041 - $19,357
417 Added 3.85%
11,259 $458,000
Q2 2021

Aug 06, 2021
BUY
$38.84 - $51.31 $16,701 - $22,063
430 Added 4.13%
10,842 $492,000
Q1 2021

May 07, 2021
BUY
$39.51 - $51.45 $22,046 - $28,709
558 Added 5.66%
10,412 $434,000
Q4 2020

Feb 16, 2021
BUY
$25.81 - $43.62 $110,931 - $187,478
4,298 Added 77.36%
9,854 $421,000
Q3 2020

Nov 09, 2020
BUY
$25.74 - $29.63 $139,536 - $160,624
5,421 Added 4015.56%
5,556 $146,000
Q4 2019

Feb 14, 2020
BUY
$14.93 - $19.53 $2,015 - $2,636
135 New
135 $2,000
Q4 2017

Feb 14, 2018
SELL
$16.75 - $20.8 $33,500 - $41,600
-2,000 Closed
0 $0
Q2 2017

Aug 11, 2017
BUY
N/A
2,000
2,000 $26,000

Others Institutions Holding HALO

# of Institutions
550
Shares Held
124M
Call Options Held
668K
Put Options Held
259K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $9.08B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email